Abstract
AIDS VACCINE RESEARCHWhen he scuttled plans for a $63 million AIDS vaccine efficacy trial last week, Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, challenged researchers to come up with a lean and mean alternative.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
